Gynecomastia screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gynecomastia}} | {{Gynecomastia}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
==Screening== | |||
*There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
*According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 01:53, 2 August 2017
|
Gynecomastia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gynecomastia screening On the Web |
|
American Roentgen Ray Society Images of Gynecomastia screening |
|
Risk calculators and risk factors for Gynecomastia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Screening
- There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
- According to the [guideline name], screening for [disease name] is not recommended.
OR
- According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].